Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects
Clinical trial NCT03018509 · COMPLETED
Trial details
- NCT number
- NCT03018509
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-06-20
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.